Ambeed.cn

首页 / / / / Halobetasol Propionate

卤倍他索丙酸酯 /Halobetasol Propionate {[allProObj[0].p_purity_real_show]}

货号:A272301 同义名: 卤贝他索丙酸酯 / Halobetasol (propionate);BMY-30056

Halobetasol Propionate is a synthetic corticosteroid with anti-inflammatory, antipruritic and vasoconstrictor activities, working as a glucocorticoid receptor agonist.

Halobetasol Propionate 化学结构 CAS号:66852-54-8
Halobetasol Propionate 化学结构
CAS号:66852-54-8
Halobetasol Propionate 3D分子结构
CAS号:66852-54-8
Halobetasol Propionate 化学结构 CAS号:66852-54-8
Halobetasol Propionate 3D分子结构 CAS号:66852-54-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Halobetasol Propionate 纯度/质量文件 产品仅供科研

货号:A272301 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

Halobetasol Propionate 生物活性

描述 Halobetasol propionate is a synthetic corticosteroid for topical dermatological use; exhibits anti-inflammatory, antipruritic, and vasoconstrictive properties. Halobetasol propionate (HP) is an effective short-term superpotent TCS (superpotent topical corticosteroids)[3]. Halobetasol propionate was distinctly more potent than clobetasol 17-propionate in the ultraviolet-induced dermatitis inhibition assay in guinea pigs and in the rat model of oxazolone-induced late inflammatory reaction. Halobetasol propionate was slightly more potent than clobetasol 17-propionate in inhibiting croton oil-induced ear edema in rats and mice and in the mouse model of oxazolone-induced early inflammatory reaction. In the cotton-pellet granuloma assay in rats and the epidermal hyperplasia inhibition assay in guinea pigs, halobetasol propionate was distinctly superior to clobetasol 17-propionate[4]. HP lotion was associated with significant reductions in disease severity in male and female participants with moderate-to-severe psoriasis, with good tolerability and safety over 8 weeks of once-daily use[5].

Halobetasol Propionate 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00234728 Psoriasis Not Applicable Completed - United States, California ... 展开 >> UCSF Psoriasis and Skin Treatment Center San Francisco, California, United States, 94118 收起 <<
NCT02045277 Plaque Psoriasis Phase 2 Completed - United States, California ... 展开 >> Valeant Site 13 Encino, California, United States, 91436 Valeant Site 11 San Diego, California, United States, 92123 Valeant Site 15 Santa Rosa, California, United States, 95403 United States, Georgia Valeant Site 10 Augusta, Georgia, United States, 30909 Valeant Site 09 Newnan, Georgia, United States, 30263 United States, Kentucky Valeant Site 08 Louisville, Kentucky, United States, 40217 United States, Maryland Valeant Site 04 Rockville, Maryland, United States, 20850 United States, Michigan Valeant Site 14 Clinton Township, Michigan, United States, 48038 United States, Minnesota Valeant Site 07 Fridley, Minnesota, United States, 55432 United States, New Jersey Valeant Site 01 East Windsor, New Jersey, United States, 08520 United States, New York Valeant Site 03 New York, New York, United States, 10075 Valeant Site 17 Rochester, New York, United States, 14623 United States, North Carolina Valeant Site 02 High Point, North Carolina, United States, 27262 United States, Texas Valeant Site 05 Austin, Texas, United States, 78759 Valeant Site 06 College Station, Texas, United States, 77845 United States, Utah Valeant Site 16 Salt Lake City, Utah, United States, 84117 United States, Virginia Valeant Site 18 Lynchburg, Virginia, United States, 24501 Valeant Site 12 Norfolk, Virginia, United States, 23507 收起 <<
NCT02514577 Plaque Psoriasis Phase 3 Completed - United States, Arkansas ... 展开 >> Valeant Site 11 Hot Springs, Arkansas, United States, 71901 United States, California Valeant Site 1 Encinitas, California, United States, 92023 Valeant Site 10 Encino, California, United States, 91436 Valeant Site 12 Santa Rosa, California, United States, 95401 United States, Georgia Valeant Site 13 Atlanta, Georgia, United States, 30301 United States, Idaho Valeant Site 7 Boise, Idaho, United States, 83701 United States, Maryland Valeant Site 6 Rockville, Maryland, United States, 20847 United States, Michigan Valeant Site 4 Ann Arbor, Michigan, United States, 48103 Valeant Site 8 Clarkston, Michigan, United States, 48346 United States, Nevada Valeant Site 15 Las Vegas, Nevada, United States, 89101 United States, North Carolina Valeant Site 9 Raleigh, North Carolina, United States, 27601 United States, Tennessee Valeant Site 5 Knoxville, Tennessee, United States, 37901 United States, Texas Valeant Site 3 Austin, Texas, United States, 73301 Valeant Site 2 San Antonio, Texas, United States, 78201 United States, Washington Valeant Site 14 Spokane, Washington, United States, 99201 收起 <<

Halobetasol Propionate 参考文献

[1]Mohandas S, Rai R, et al. Halobetasol versus clobetasol: a study of potency. Indian J Dermatol Venereol Leprol. 2009 Mar-Apr;75(2):186-7.

[2]Kantor I, Cook PR, et al. Double-blind bilateral paired comparison of 0.05% halobetasol propionate cream and its vehicle in patients with chronic atopic dermatitis and other eczematous dermatoses. J Am Acad Dermatol. 1991 Dec;25(6 Pt 2):1184-6.

[3]Bagel J, Thibodeaux QG, Han G. Halobetasol propionate for the management of psoriasis. Cutis. 2020 Feb;105(2):92-96;E4

[4]Yawalkar S, Wiesenberg-Boettcher I, Gibson JR, Siskin SB, Pignat W. Dermatopharmacologic investigations of halobetasol propionate in comparison with clobetasol 17-propionate. J Am Acad Dermatol. 1991 Dec;25(6 Pt 2):1137-44

[5]Cook-Bolden FE, Hebert AA, Guenthner ST, Kang R, Martin G, Jacobson A. Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants. J Drugs Dermatol. 2020 Aug 1;19(8):747-754

Halobetasol Propionate 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.06mL

0.41mL

0.21mL

10.31mL

2.06mL

1.03mL

20.62mL

4.12mL

2.06mL

Halobetasol Propionate 技术信息

CAS号66852-54-8
分子式C25H31ClF2O5
分子量 484.961
别名 卤贝他索丙酸酯 ;Halobetasol (propionate);BMY-30056;Ultravate;Ulobetasol propionate;CGP-14458
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,2-8°C

溶解度
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。